These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 18714175)

  • 21. Nuclear receptor: Structure and function.
    Sar P
    Prog Mol Biol Transl Sci; 2023; 196():209-227. PubMed ID: 36813359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nuclear receptor and transcriptional complex cycles.
    Fowler AM; Alarid ET
    Sci STKE; 2004 Dec; 2004(262):tr11. PubMed ID: 15585691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evolution of Nuclear Receptors and Ligand Signaling: Toward a Soft Key-Lock Model?
    Holzer G; Markov GV; Laudet V
    Curr Top Dev Biol; 2017; 125():1-38. PubMed ID: 28527568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting Nuclear Receptors with PROTAC degraders.
    Flanagan JJ; Neklesa TK
    Mol Cell Endocrinol; 2019 Aug; 493():110452. PubMed ID: 31125586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functions of Nutrient-Sensing Nuclear Receptors in Health.
    Yamaji R
    J Nutr Sci Vitaminol (Tokyo); 2022; 68(Supplement):S14-S16. PubMed ID: 36436998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nuclear receptors in bone physiology and diseases.
    Imai Y; Youn MY; Inoue K; Takada I; Kouzmenko A; Kato S
    Physiol Rev; 2013 Apr; 93(2):481-523. PubMed ID: 23589826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. General molecular biology and architecture of nuclear receptors.
    Pawlak M; Lefebvre P; Staels B
    Curr Top Med Chem; 2012; 12(6):486-504. PubMed ID: 22242852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ubiquitination of nuclear receptors.
    El Hokayem J; Amadei C; Obeid JP; Nawaz Z
    Clin Sci (Lond); 2017 May; 131(10):917-934. PubMed ID: 28473472
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determination of Molecule Category of Ligands Targeting the Ligand-Binding Pocket of Nuclear Receptors with Structural Elucidation and Machine Learning.
    Wang Q; Wang Z; Tian S; Wang L; Tang R; Yu Y; Ge J; Hou T; Hao H; Sun H
    J Chem Inf Model; 2022 Sep; 62(17):3993-4007. PubMed ID: 36040137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Minireview: Familiar Faces in Unfamiliar Places: The Emerging Role of Nuclear Receptors in Lung Cancer.
    Yenerall P; Kittler R
    Mol Endocrinol; 2015 Dec; 29(12):1675-83. PubMed ID: 26484581
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacogenomics opportunities in nuclear receptor targeted cancer therapy.
    Schapira M
    Curr Cancer Drug Targets; 2002 Sep; 2(3):243-56. PubMed ID: 12188910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The evolution of the nuclear receptor superfamily.
    Escriva H; Bertrand S; Laudet V
    Essays Biochem; 2004; 40():11-26. PubMed ID: 15242336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systematic Pan-Cancer Characterization of Nuclear Receptors Identifies Potential Cancer Biomarkers and Therapeutic Targets.
    Jiang J; Yuan J; Hu Z; Xu M; Zhang Y; Long M; Fan Y; Montone KT; Tanyi JL; Tavana O; Chan HM; Zhang L; Hu X
    Cancer Res; 2022 Jan; 82(1):46-59. PubMed ID: 34750098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nuclear receptors in oral cancer-Emerging players in tumorigenesis.
    Gangwar SK; Kumar A; Jose S; Alqahtani MS; Abbas M; Sethi G; Kunnumakkara AB
    Cancer Lett; 2022 Jun; 536():215666. PubMed ID: 35364221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Demystifying the Functional Role of Nuclear Receptors in Esophageal Cancer.
    Jayaprakash S; Hegde M; Girisa S; Alqahtani MS; Abbas M; Lee EHC; Yap KC; Sethi G; Kumar AP; Kunnumakkara AB
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of phosphorylated estrogen receptor beta is an independent negative prognostic factor for pancreatic ductal adenocarcinoma.
    Pozios I; Knösel T; Zhao Y; Assmann G; Pozios I; Müller MH; Bruns CJ; Kreis ME; Seeliger H
    J Cancer Res Clin Oncol; 2018 Oct; 144(10):1887-1897. PubMed ID: 30046904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nuclear receptors and pathogenesis of pancreatic cancer.
    Polvani S; Tarocchi M; Tempesti S; Galli A
    World J Gastroenterol; 2014 Sep; 20(34):12062-81. PubMed ID: 25232244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primers on molecular pathways: nuclear receptors in pancreatic cancer. The ligand-independent way.
    Nacusi LP; Debes JD
    Pancreatology; 2008; 8(4-5):422-4. PubMed ID: 18714175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evolution of the repertoire of nuclear receptor binding sites in genomes.
    Cotnoir-White D; Laperrière D; Mader S
    Mol Cell Endocrinol; 2011 Mar; 334(1-2):76-82. PubMed ID: 21056084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
    Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.